commit 76201feb251c2058792f9cf480d515ad9cf39106
Author: David Lagorce <david.lagorce@inserm.fr>
Date:   Wed Jul 7 12:35:15 2021 +0200

    JULY 2021

diff --git a/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml b/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml
old mode 100644
new mode 100755
index 88d22e6..62cb1da
--- a/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml	
+++ b/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml	
@@ -1,5 +1,5 @@
 <?xml version="1.0" encoding="ISO-8859-1"?>
-<JDBOR date="2021-06-01 04:47:14" version="1.3.7 / 4.1.7 [2020-12-03] (orientdb version)" copyright="Orphanet (c) 2021" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
+<JDBOR date="2021-07-01 04:48:37" version="1.3.7 / 4.1.7 [2020-12-03] (orientdb version)" copyright="Orphanet (c) 2021" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
   <Availability> 
     <Licence>
       <FullName lang="en">Creative Commons Attribution 4.0 International</FullName>
@@ -17493,9 +17493,9 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="1">
         <Prevalence id="8297">
-          <Source>20345937[PMID]_[EXPERT]</Source>
+          <Source>PMID: 22911482</Source>
           <PrevalenceType id="23676">
             <Name lang="nl">Jaarlijkse incidentie</Name>
           </PrevalenceType>
@@ -17513,25 +17513,6 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="8298">
-          <Source>20345937[PMID]_22911482[PMID]_ [EXPERT]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>1.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="190">
@@ -17691,7 +17672,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="8288">
           <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
@@ -17711,6 +17692,21 @@
             <Name lang="nl">Not yet validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="16425">
+          <Source/>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>28.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus/>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="176">
@@ -19633,7 +19629,7 @@
     <Disorder id="194">
       <OrphaCode>60</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=60</ExpertLink>
-      <Name lang="nl">Alfa-1-antitrypsinedeficiëntie</Name>
+      <Name lang="nl">Deficiëntie van alfa-1-antitrypsine</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -30055,7 +30051,7 @@
     <Disorder id="447">
       <OrphaCode>200</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=200</ExpertLink>
-      <Name lang="nl">Geïsoleerde agenesie van het corpus callosum</Name>
+      <Name lang="nl">Geïsoleerde agenesie van corpus callosum</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -39754,7 +39750,7 @@
     <Disorder id="538">
       <OrphaCode>2444</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2444</ExpertLink>
-      <Name lang="nl">Congenitale pulmonale luchtwegmalformatie</Name>
+      <Name lang="nl">Congenitale malformatie van pulmonale luchtwegen</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -46148,9 +46144,9 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="7">
+      <PrevalenceList count="8">
         <Prevalence id="1689">
-          <Source>European Medicines Agency 2015[INST]</Source>
+          <Source>PMID: 31769437, 25944380, 24715559</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -46160,16 +46156,16 @@
           <PrevalenceClass id="23732">
             <Name lang="nl">1-5 / 10 000</Name>
           </PrevalenceClass>
-          <ValMoy>10.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
+          <ValMoy>8.06</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="1690">
-          <Source>2785882[PMID]</Source>
+          <Source>PMID: 2785882</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -46179,7 +46175,7 @@
           <PrevalenceClass id="23746">
             <Name lang="nl">1-9 / 100 000</Name>
           </PrevalenceClass>
-          <ValMoy>6.7</ValMoy>
+          <ValMoy>6.4</ValMoy>
           <PrevalenceGeographic id="24369">
             <Name lang="nl">France</Name>
           </PrevalenceGeographic>
@@ -46187,27 +46183,8 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="1691">
-          <Source>12389865[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>6.7</ValMoy>
-          <PrevalenceGeographic id="24362">
-            <Name lang="nl">Finland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
         <Prevalence id="1692">
-          <Source>22407836[PMID]</Source>
+          <Source>PMID: 3746832</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -46217,7 +46194,7 @@
           <PrevalenceClass id="23739">
             <Name lang="nl">1-9 / 1 000 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.74</ValMoy>
+          <ValMoy>0.4</ValMoy>
           <PrevalenceGeographic id="23816">
             <Name lang="nl">Latijs-Amerika</Name>
           </PrevalenceGeographic>
@@ -46226,7 +46203,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="1693">
-          <Source>22375084[PMID]</Source>
+          <Source>PMID: 22375084</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -46245,7 +46222,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="1694">
-          <Source>22461456[PMID]</Source>
+          <Source>PMID: 22461456, 24715559</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -46255,7 +46232,7 @@
           <PrevalenceClass id="23746">
             <Name lang="nl">1-9 / 100 000</Name>
           </PrevalenceClass>
-          <ValMoy>7.9</ValMoy>
+          <ValMoy>6.95</ValMoy>
           <PrevalenceGeographic id="25482">
             <Name lang="nl">United States</Name>
           </PrevalenceGeographic>
@@ -46264,7 +46241,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="11269">
-          <Source>25944380[PMID]</Source>
+          <Source>PMID: 25944380</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -46282,6 +46259,40 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="16436">
+          <Source>PMID: 22913777</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>1314.0</ValMoy>
+          <PrevalenceGeographic id="24166">
+            <Name lang="nl">China</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="16435">
+          <Source>PMID: 26627451</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>72.0</ValMoy>
+          <PrevalenceGeographic id="25356">
+            <Name lang="nl">Taiwan, Province of China</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="17999">
@@ -47189,275 +47200,9 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="27">
+      <PrevalenceList count="4">
         <Prevalence id="1622">
-          <Source>25066220[PMID]_EUROCAT European surveillance of congenital anomalies 1980-2009[REG]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>10.9</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1624">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1626">
-          <Source>EUROCAT European surveillance of congenital anomalies 2010[REG]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>5.8</ValMoy>
-          <PrevalenceGeographic id="24005">
-            <Name lang="nl">Belgium</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1627">
-          <Source>EUROCAT European surveillance of congenital anomalies 2008[REG]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>13.1</ValMoy>
-          <PrevalenceGeographic id="24236">
-            <Name lang="nl">Croatia</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1628">
-          <Source>EUROCAT European surveillance of congenital anomalies 2010[REG]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>19.8</ValMoy>
-          <PrevalenceGeographic id="24264">
-            <Name lang="nl">Denmark</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1629">
-          <Source>EUROCAT European surveillance of congenital anomalies 2010[REG]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>13.6</ValMoy>
-          <PrevalenceGeographic id="24369">
-            <Name lang="nl">France</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1630">
-          <Source>EUROCAT European surveillance of congenital anomalies 2010[REG]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>11.6</ValMoy>
-          <PrevalenceGeographic id="24418">
-            <Name lang="nl">Germany</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1631">
-          <Source>EUROCAT European surveillance of congenital anomalies 2010[REG]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>5.5</ValMoy>
-          <PrevalenceGeographic id="24544">
-            <Name lang="nl">Hungary</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1632">
-          <Source>EUROCAT European surveillance of congenital anomalies 2010[REG]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>18.1</ValMoy>
-          <PrevalenceGeographic id="24586">
-            <Name lang="nl">Ireland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1633">
-          <Source>EUROCAT European surveillance of congenital anomalies 2010[REG]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>23.3</ValMoy>
-          <PrevalenceGeographic id="24607">
-            <Name lang="nl">Italy</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1635">
-          <Source>EUROCAT European surveillance of congenital anomalies 2010[REG]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>11.4</ValMoy>
-          <PrevalenceGeographic id="24936">
-            <Name lang="nl">Netherlands</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1637">
-          <Source>EUROCAT European surveillance of congenital anomalies 2010[REG]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>1.0</ValMoy>
-          <PrevalenceGeographic id="25083">
-            <Name lang="nl">Poland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1638">
-          <Source>EUROCAT European surveillance of congenital anomalies 2010[REG]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>9.5</ValMoy>
-          <PrevalenceGeographic id="25090">
-            <Name lang="nl">Portugal</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1639">
-          <Source>EUROCAT European surveillance of congenital anomalies 2010[REG]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>6.9</ValMoy>
-          <PrevalenceGeographic id="25293">
-            <Name lang="nl">Spain</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1640">
-          <Source>EUROCAT European surveillance of congenital anomalies 2010[REG]</Source>
+          <Source>PMID: 25066220 &amp; Eurocat</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -47467,35 +47212,16 @@
           <PrevalenceClass id="23732">
             <Name lang="nl">1-5 / 10 000</Name>
           </PrevalenceClass>
-          <ValMoy>12.3</ValMoy>
-          <PrevalenceGeographic id="25342">
-            <Name lang="nl">Switzerland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1642">
-          <Source>EUROCAT European surveillance of congenital anomalies 2010[REG]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>16.2</ValMoy>
-          <PrevalenceGeographic id="25461">
-            <Name lang="nl">Ukraine</Name>
+          <ValMoy>13.2</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="nl">Europa</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="1643">
-          <Source>6240474[PMID]_19777544[PMID]</Source>
+          <Source>PMID: 27702942</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -47505,35 +47231,16 @@
           <PrevalenceClass id="23732">
             <Name lang="nl">1-5 / 10 000</Name>
           </PrevalenceClass>
-          <ValMoy>24.3</ValMoy>
+          <ValMoy>21.0</ValMoy>
           <PrevalenceGeographic id="25482">
             <Name lang="nl">United States</Name>
           </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1644">
-          <Source>15868585[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>18.7</ValMoy>
-          <PrevalenceGeographic id="24621">
-            <Name lang="nl">Japan</Name>
-          </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="1645">
-          <Source>4049274[PMID]</Source>
+        <Prevalence id="16447">
+          <Source>PMID: 27118113</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -47543,111 +47250,16 @@
           <PrevalenceClass id="23732">
             <Name lang="nl">1-5 / 10 000</Name>
           </PrevalenceClass>
-          <ValMoy>22.6</ValMoy>
-          <PrevalenceGeographic id="23949">
-            <Name lang="nl">Australia</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1646">
-          <Source>9165461[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>32.6</ValMoy>
-          <PrevalenceGeographic id="25013">
-            <Name lang="nl">Oman</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1623">
-          <Source>EUROCAT European surveillance of congenital anomalies 2010[REG]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1625">
-          <Source>EUROCAT European surveillance of congenital anomalies 2010[REG]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>9.8</ValMoy>
-          <PrevalenceGeographic id="23956">
-            <Name lang="nl">Austria</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1634">
-          <Source>EUROCAT European surveillance of congenital anomalies 2010[REG]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>24.1</ValMoy>
-          <PrevalenceGeographic id="24803">
-            <Name lang="nl">Malta</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1636">
-          <Source>EUROCAT European surveillance of congenital anomalies 2010[REG]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>11.2</ValMoy>
-          <PrevalenceGeographic id="25006">
-            <Name lang="nl">Norway</Name>
+          <ValMoy>0.22</ValMoy>
+          <PrevalenceGeographic id="25356">
+            <Name lang="nl">Taiwan, Province of China</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="1641">
-          <Source>EUROCAT European surveillance of congenital anomalies 2010[REG]</Source>
+        <Prevalence id="16448">
+          <Source>PMID: 31644668; 27702942</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -47657,47 +47269,9 @@
           <PrevalenceClass id="23732">
             <Name lang="nl">1-5 / 10 000</Name>
           </PrevalenceClass>
-          <ValMoy>15.5</ValMoy>
-          <PrevalenceGeographic id="25475">
-            <Name lang="nl">United Kingdom</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1647">
-          <Source>15921246[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>33.0</ValMoy>
-          <PrevalenceGeographic id="23851">
-            <Name lang="nl">Specifieke populatie</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="12566">
-          <Source>27307146[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>1.91</ValMoy>
-          <PrevalenceGeographic id="25335">
-            <Name lang="nl">Sweden</Name>
+          <ValMoy>10.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
@@ -47798,304 +47372,38 @@
       <DisorderGroup id="36540">
         <Name lang="nl">Groep van aandoeningen</Name>
       </DisorderGroup>
-      <PrevalenceList count="20">
+      <PrevalenceList count="4">
         <Prevalence id="1580">
-          <Source>20507631[PMID]_[EXPERT]</Source>
+          <Source>PMID: 20566927, 25201089, 33095945</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
           <PrevalenceQualification id="23711">
             <Name lang="nl">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>1.8</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1581">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>2.2</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1582">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1583">
-          <Source>20507631[PMID]_[EXPERT]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>1.9</ValMoy>
-          <PrevalenceGeographic id="25482">
-            <Name lang="nl">United States</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1584">
-          <Source>20507631[PMID]_[EXPERT]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
           <PrevalenceClass id="23739">
             <Name lang="nl">1-9 / 1 000 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="25482">
-            <Name lang="nl">United States</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1585">
-          <Source>6203284[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>1.51</ValMoy>
-          <PrevalenceGeographic id="24362">
-            <Name lang="nl">Finland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1586">
-          <Source>6203284[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="24362">
-            <Name lang="nl">Finland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1587">
-          <Source>1419751[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>2.8</ValMoy>
-          <PrevalenceGeographic id="24586">
-            <Name lang="nl">Ireland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1588">
-          <Source>1419751[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="24586">
-            <Name lang="nl">Ireland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1589">
-          <Source>ISBN:801812658[OTHER]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>2.43</ValMoy>
-          <PrevalenceGeographic id="25006">
-            <Name lang="nl">Norway</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1590">
-          <Source>ISBN:801812658[OTHER]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="25006">
-            <Name lang="nl">Norway</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1591">
-          <Source>2601109[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.4</ValMoy>
-          <PrevalenceGeographic id="24621">
-            <Name lang="nl">Japan</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1592">
-          <Source>2601109[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="24621">
-            <Name lang="nl">Japan</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1593">
-          <Source>ISBN:951563203[OTHER]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.08</ValMoy>
-          <PrevalenceGeographic id="25279">
-            <Name lang="nl">South Africa</Name>
+          <ValMoy>0.656</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="1594">
-          <Source>ISBN:951563203[OTHER]</Source>
+        <Prevalence id="16444">
+          <Source>PMID: 20566927</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="25279">
-            <Name lang="nl">South Africa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1595">
-          <Source>20566927[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
           <PrevalenceQualification id="23711">
             <Name lang="nl">Value and class</Name>
           </PrevalenceQualification>
           <PrevalenceClass id="23739">
             <Name lang="nl">1-9 / 1 000 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.56</ValMoy>
+          <ValMoy>0.58</ValMoy>
           <PrevalenceGeographic id="23949">
             <Name lang="nl">Australia</Name>
           </PrevalenceGeographic>
@@ -48103,8 +47411,8 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="1596">
-          <Source>20566927[PMID]</Source>
+        <Prevalence id="16445">
+          <Source>PMID: 33095945</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -48114,66 +47422,28 @@
           <PrevalenceClass id="23746">
             <Name lang="nl">1-9 / 100 000</Name>
           </PrevalenceClass>
-          <ValMoy>1.05</ValMoy>
-          <PrevalenceGeographic id="23949">
-            <Name lang="nl">Australia</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1597">
-          <Source>20566927[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.29</ValMoy>
-          <PrevalenceGeographic id="24957">
-            <Name lang="nl">New Zealand</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="1598">
-          <Source>20566927[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="24957">
-            <Name lang="nl">New Zealand</Name>
+          <ValMoy>1.19</ValMoy>
+          <PrevalenceGeographic id="24936">
+            <Name lang="nl">Netherlands</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="1599">
-          <Source>9155958[PMID]_[EXPERT]</Source>
+        <Prevalence id="16446">
+          <Source>PMID: 25201089</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
           <PrevalenceQualification id="23711">
             <Name lang="nl">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
           </PrevalenceClass>
-          <ValMoy>2.86</ValMoy>
-          <PrevalenceGeographic id="25475">
-            <Name lang="nl">United Kingdom</Name>
+          <ValMoy>0.197</ValMoy>
+          <PrevalenceGeographic id="25118">
+            <Name lang="nl">Romania</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
@@ -49897,7 +49167,7 @@
     <Disorder id="658">
       <OrphaCode>768</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=768</ExpertLink>
-      <Name lang="nl">Familiaal lange QT-syndroom</Name>
+      <Name lang="nl">Familiaal lang-QT-syndroom</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -53025,85 +52295,9 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="11">
-        <Prevalence id="2060">
-          <Source>20301491[PMID]_22889154[PMID]_ [EXPERT]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>5.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2061">
-          <Source>8272182[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.5</ValMoy>
-          <PrevalenceGeographic id="24369">
-            <Name lang="nl">France</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2062">
-          <Source>9286459[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.8</ValMoy>
-          <PrevalenceGeographic id="24418">
-            <Name lang="nl">Germany</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2063">
-          <Source>23419472[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>1.6</ValMoy>
-          <PrevalenceGeographic id="25006">
-            <Name lang="nl">Norway</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2064">
-          <Source>23419472[PMID]</Source>
+      <PrevalenceList count="2">
+        <Prevalence id="16438">
+          <Source>PMID: 23419472</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -53121,120 +52315,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="2065">
-          <Source>10933453[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>1.8</ValMoy>
-          <PrevalenceGeographic id="24607">
-            <Name lang="nl">Italy</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2066">
-          <Source>9556302[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>1.6</ValMoy>
-          <PrevalenceGeographic id="23802">
-            <Name lang="nl">Oceanië</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2067">
-          <Source>12436195[PMID]_ORPHANET</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>1.35</ValMoy>
-          <PrevalenceGeographic id="24621">
-            <Name lang="nl">Japan</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2068">
-          <Source>19269120[PMID]</Source>
+        <Prevalence id="16439">
+          <Source>PMID: 31074578</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
           <PrevalenceQualification id="23711">
             <Name lang="nl">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>1.4</ValMoy>
-          <PrevalenceGeographic id="24068">
-            <Name lang="nl">Brazil</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2069">
-          <Source>[EXPERT]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
           </PrevalenceClass>
-          <ValMoy>5.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
+          <ValMoy>2.0639</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="2070">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="766">
@@ -62072,7 +61171,7 @@
     <Disorder id="815">
       <OrphaCode>549</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=549</ExpertLink>
-      <Name lang="nl">Legionellose</Name>
+      <Name lang="nl">Veteranenziekte</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -65936,7 +65035,7 @@
     <Disorder id="894">
       <OrphaCode>3451</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3451</ExpertLink>
-      <Name lang="nl">Syndroom van West</Name>
+      <Name lang="nl">Syndroom van infantiele spasmen</Name>
       <DisorderType id="21422">
         <Name lang="nl">Klinisch syndroom</Name>
       </DisorderType>
@@ -67079,9 +66178,9 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="23">
+      <PrevalenceList count="19">
         <Prevalence id="2360">
-          <Source>18681890[PMID]</Source>
+          <Source>PMID: 28595941</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -67099,27 +66198,8 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="2361">
-          <Source>18681890[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>7.6</ValMoy>
-          <PrevalenceGeographic id="25335">
-            <Name lang="nl">Sweden</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
         <Prevalence id="2362">
-          <Source>18681890[PMID]</Source>
+          <Source>PMID: 18681890</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -67157,7 +66237,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="2364">
-          <Source>18681890[PMID]</Source>
+          <Source>PMID: 18681890</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -67194,46 +66274,8 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="2366">
-          <Source>16435194[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.38</ValMoy>
-          <PrevalenceGeographic id="24418">
-            <Name lang="nl">Germany</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2367">
-          <Source>9439667[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>1.31</ValMoy>
-          <PrevalenceGeographic id="24586">
-            <Name lang="nl">Ireland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
         <Prevalence id="2368">
-          <Source>20490927[PMID]</Source>
+          <Source>PMID: 20490927</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -67251,27 +66293,8 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="2369">
-          <Source>10617747[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.39</ValMoy>
-          <PrevalenceGeographic id="24124">
-            <Name lang="nl">Canada</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
         <Prevalence id="2370">
-          <Source>20209839[PMID]</Source>
+          <Source>PMID: 20209839</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -67290,7 +66313,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="2371">
-          <Source>19396827[PMID]</Source>
+          <Source>PMID: 19396827</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -67309,22 +66332,22 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="2372">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
+          <Source>PMID: 28595941</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
+          <ValMoy>0.45</ValMoy>
           <PrevalenceGeographic id="23795">
             <Name lang="nl">Europa</Name>
           </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="11720">
@@ -67347,7 +66370,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="11721">
-          <Source>25472774[PMID]</Source>
+          <Source>PMID: 25472774</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -67366,7 +66389,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="13922">
-          <Source>28595941[PMID]</Source>
+          <Source>PMID: 28595941</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -67385,7 +66408,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="13923">
-          <Source>28595941[PMID]</Source>
+          <Source>PMID: 28595941</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -67404,7 +66427,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="13924">
-          <Source>20622343[PMID]</Source>
+          <Source>PMID: 20622343</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -67423,7 +66446,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="13925">
-          <Source>25364648[PMID]</Source>
+          <Source>PMID: 25364648</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -67441,8 +66464,8 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="13926">
-          <Source>9918480[PMID]</Source>
+        <Prevalence id="13927">
+          <Source>PMID: 34051828</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -67452,26 +66475,7 @@
           <PrevalenceClass id="23739">
             <Name lang="nl">1-9 / 1 000 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.59</ValMoy>
-          <PrevalenceGeographic id="23949">
-            <Name lang="nl">Australia</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="13927">
-          <Source>DOI: https://doi.org/10.1016/j.ymgme.2016.11.285[OTHER]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.09</ValMoy>
+          <ValMoy>0.14</ValMoy>
           <PrevalenceGeographic id="25482">
             <Name lang="nl">United States</Name>
           </PrevalenceGeographic>
@@ -67480,7 +66484,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="13928">
-          <Source>DOI: https://doi.org/10.1016/j.ymgme.2014.12.082[OTHER]</Source>
+          <Source>PMID: 31926052</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -67499,7 +66503,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="13929">
-          <Source>14685153[PMID]</Source>
+          <Source>PMID: 14685153</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -67517,6 +66521,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="16437">
+          <Source>PMID: 28595941</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.07</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="873">
@@ -77849,7 +76872,7 @@
     <Disorder id="972">
       <OrphaCode>776</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=776</ExpertLink>
-      <Name lang="nl">X-gebonden intellectuele achterstand met marfanoïde habitus</Name>
+      <Name lang="nl">Syndroom van Lujan-Fryns</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -80322,7 +79345,7 @@
     <Disorder id="1058">
       <OrphaCode>557</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=557</ExpertLink>
-      <Name lang="nl">Geïsoleerde anorectale malformatie</Name>
+      <Name lang="nl">Niet-syndromale anorectale malformatie</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -83398,7 +82421,7 @@
     <Disorder id="1276">
       <OrphaCode>955</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=955</ExpertLink>
-      <Name lang="nl">Acro-osteolyse, dominant type</Name>
+      <Name lang="nl">Syndroom van Hajdu-Cheney</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -83675,7 +82698,7 @@
     <Disorder id="1190">
       <OrphaCode>1762</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1762</ExpertLink>
-      <Name lang="nl">Trisomie Xq28</Name>
+      <Name lang="nl">Proximale Xq28-duplicatiesyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -98644,9 +97667,9 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="1">
         <Prevalence id="3219">
-          <Source>9326330[PMID]</Source>
+          <Source>PMID: 9326330</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -98664,25 +97687,6 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="3220">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="16907">
@@ -109662,7 +108666,7 @@
     <Disorder id="1962">
       <OrphaCode>2036</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2036</ExpertLink>
-      <Name lang="nl">Schedelhuid-oor-tepelsyndroom</Name>
+      <Name lang="nl">Scalp - oor - tepel-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -129663,7 +128667,7 @@
     <Disorder id="19853">
       <OrphaCode>261144</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=261144</ExpertLink>
-      <Name lang="nl">14q12 microdeletiesyndroom</Name>
+      <Name lang="nl">FOXG1-syndroom door 14q12-microdeletie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -132962,6 +131966,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2726">
+      <OrphaCode>3033</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3033</ExpertLink>
+      <Name lang="nl">Renale tubulaire dysgenesie</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="16443">
+          <Source>PMID: 16790508; 19344005; 33163725</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="20071">
       <OrphaCode>263553</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=263553</ExpertLink>
@@ -135357,7 +134393,7 @@
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="12669">
-          <Source>2133981[PMID]</Source>
+          <Source>PMID: 24053747</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Cases/families</Name>
           </PrevalenceType>
@@ -135365,7 +134401,7 @@
             <Name lang="nl">Case</Name>
           </PrevalenceQualification>
           <PrevalenceClass/>
-          <ValMoy>2.0</ValMoy>
+          <ValMoy>19.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -135374,7 +134410,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="12670">
-          <Source>ORPHANET_2133981[PMID]</Source>
+          <Source>PMID: 24053747</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -141681,7 +140717,7 @@
     <Disorder id="2648">
       <OrphaCode>2934</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2934</ExpertLink>
-      <Name lang="nl">Polysyndactylie - hartmisvorming</Name>
+      <Name lang="nl">Polysyndactylie - hartmalformatie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -150560,14 +149596,14 @@
     <Disorder id="2823">
       <OrphaCode>647</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=647</ExpertLink>
-      <Name lang="nl">Nijmegen breuksyndroom</Name>
+      <Name lang="nl">Nijmegen-breuksyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="8">
         <Prevalence id="4063">
           <Source>20301355[PMID]</Source>
           <PrevalenceType id="23683">
@@ -150602,8 +149638,122 @@
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="16426">
+          <Source>PMID: 33488600</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.7</ValMoy>
+          <PrevalenceGeographic id="25125">
+            <Name lang="nl">Russian Federation</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="16427">
+          <Source>PMID: 33488600</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>3.1</ValMoy>
+          <PrevalenceGeographic id="25083">
+            <Name lang="nl">Poland</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="16428">
+          <Source>PMID: 33488600</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>3.1</ValMoy>
+          <PrevalenceGeographic id="24257">
+            <Name lang="nl">Czech Republic</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="16429">
+          <Source>PMID: 33488600</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>2.6</ValMoy>
+          <PrevalenceGeographic id="25251">
+            <Name lang="nl">Slovakia</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="16430">
+          <Source>PMID: 33488600</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>2.3</ValMoy>
+          <PrevalenceGeographic id="23998">
+            <Name lang="nl">Belarus</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="16431">
+          <Source>PMID: 33488600</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.3</ValMoy>
+          <PrevalenceGeographic id="25461">
+            <Name lang="nl">Ukraine</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
       </PrevalenceList>
@@ -155698,7 +154848,7 @@
     <Disorder id="3297">
       <OrphaCode>6</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=6</ExpertLink>
-      <Name lang="nl">3-methylcrotonyl-CoA-carboxylasedeficiëntie</Name>
+      <Name lang="nl">Deficiëntie van 3-methylcrotonyl-CoA-carboxylase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -158675,7 +157825,7 @@
     <Disorder id="3150">
       <OrphaCode>2427</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2427</ExpertLink>
-      <Name lang="nl">Macrocefalie - kleine gestalte - paraplegie</Name>
+      <Name lang="nl">Macrocefalie - kleine gestalte - paraplegie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -159250,7 +158400,7 @@
     <Disorder id="3183">
       <OrphaCode>3051</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3051</ExpertLink>
-      <Name lang="nl">Intellectuele achterstand - dun haar - brachydactylie</Name>
+      <Name lang="nl">Syndroom van Nicolaides-Baraitser</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -171113,7 +170263,7 @@
     <Disorder id="18807">
       <OrphaCode>217008</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=217008</ExpertLink>
-      <Name lang="nl">Bockenheimersyndroom</Name>
+      <Name lang="nl">Syndroom van Bockenheimer</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -174951,7 +174101,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="3">
+      <PrevalenceList count="2">
         <Prevalence id="4575">
           <Source>24008954[PMID]</Source>
           <PrevalenceType id="23676">
@@ -174990,25 +174140,6 @@
             <Name lang="nl">Not yet validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="11225">
-          <Source>22790125[PMID]_[EXPERT]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>38.0</ValMoy>
-          <PrevalenceGeographic id="24621">
-            <Name lang="nl">Japan</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="3443">
@@ -178306,55 +177437,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="18950">
-      <OrphaCode>221150</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=221150</ExpertLink>
-      <Name lang="nl">Pitt-Hopkins-achtig syndroom</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="8841">
-          <Source>22670138[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>105.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8842">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="19062">
       <OrphaCode>228003</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228003</ExpertLink>
@@ -189318,11 +188400,11 @@
       <OrphaCode>238593</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=238593</ExpertLink>
       <Name lang="nl">IgG4-gerelateerde mesenteritis</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="9014">
@@ -191035,7 +190117,7 @@
       <DisorderGroup id="36554">
         <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="1">
         <Prevalence id="12221">
           <Source>27056062[PMID]</Source>
           <PrevalenceType id="23676">
@@ -191055,24 +190137,35 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="12931">
-          <Source>European Medicines Agency 2018[INST]</Source>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="21946">
+      <OrphaCode>329903</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=329903</ExpertLink>
+      <Name lang="nl">Immunoglobuline-gemedieerde membranoproliferatieve glomerulonefritis</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
+      </DisorderType>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="16424">
+          <Source/>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
           <PrevalenceQualification id="23711">
             <Name lang="nl">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
           </PrevalenceClass>
-          <ValMoy>12.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
+          <PrevalenceValidationStatus/>
         </Prevalence>
       </PrevalenceList>
     </Disorder>
@@ -196999,7 +196092,7 @@
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="13183">
-          <Source>27777327[PMID]</Source>
+          <Source>ftp://ftp.sanger.ac.uk/pub/resources/theses/wj1/</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Cases/families</Name>
           </PrevalenceType>
@@ -197007,7 +196100,7 @@
             <Name lang="nl">Case</Name>
           </PrevalenceQualification>
           <PrevalenceClass/>
-          <ValMoy>18.0</ValMoy>
+          <ValMoy>84.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -206088,7 +205181,7 @@
     <Disorder id="22081">
       <OrphaCode>352577</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=352577</ExpertLink>
-      <Name lang="nl">Ernstige voedingsproblemen - groeifalen - microcefalie door ASXL3-deficiëntie-syndroom</Name>
+      <Name lang="nl">Syndroom van Bainbridge-Ropers</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -208257,7 +207350,7 @@
     <Disorder id="20892">
       <OrphaCode>293939</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=293939</ExpertLink>
-      <Name lang="nl">Distale Xq28 microduplicatiesyndroom</Name>
+      <Name lang="nl">Distale Xq28-microduplicatiesyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -214748,7 +213841,7 @@
     <Disorder id="21462">
       <OrphaCode>313906</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=313906</ExpertLink>
-      <Name lang="nl">Congenitale pancreatische cyste</Name>
+      <Name lang="nl">Congenitale cyste van pancreas</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -221573,7 +220666,7 @@
     <Disorder id="24015">
       <OrphaCode>464306</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=464306</ExpertLink>
-      <Name lang="nl">DYRK1A-gerelateerde intellectuele achterstand-syndroom</Name>
+      <Name lang="nl">Intellectuele achterstand-syndroom gerelateerd aan DYRK1A</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -222917,7 +222010,7 @@
     <Disorder id="23649">
       <OrphaCode>453533</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=453533</ExpertLink>
-      <Name lang="nl">Polyendocrien-polyneuropathiesyndroom</Name>
+      <Name lang="nl">Polyendocrinopathie - polyneuropathie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -223373,7 +222466,7 @@
     <Disorder id="23635">
       <OrphaCode>450322</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=450322</ExpertLink>
-      <Name lang="nl">Polyklonaal hyperviscositeitssyndroom</Name>
+      <Name lang="nl">Polyklonale hyperviscositeitssyndroom</Name>
       <DisorderType id="21422">
         <Name lang="nl">Klinisch syndroom</Name>
       </DisorderType>
@@ -223455,11 +222548,11 @@
       <OrphaCode>449563</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=449563</ExpertLink>
       <Name lang="nl">IgG4-gerelateerde oftalmische ziekte</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="12162">
@@ -223519,11 +222612,11 @@
       <OrphaCode>449400</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=449400</ExpertLink>
       <Name lang="nl">IgG4-gerelateerde aortitis</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="12165">
@@ -223551,11 +222644,11 @@
       <OrphaCode>449395</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=449395</ExpertLink>
       <Name lang="nl">IgG4-gerelateerde nierziekte</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="12166">
@@ -223583,11 +222676,11 @@
       <OrphaCode>449432</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=449432</ExpertLink>
       <Name lang="nl">IgG4-gerelateerde submandibulaire klierziekte</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="12163">
@@ -223615,11 +222708,11 @@
       <OrphaCode>449427</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=449427</ExpertLink>
       <Name lang="nl">IgG4-gerelateerde pachymeningitis</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="12164">
@@ -228140,7 +227233,7 @@
     <Disorder id="24223">
       <OrphaCode>468631</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=468631</ExpertLink>
-      <Name lang="nl">Microcefale primordiale dwerggroei door RTTN-deficiëntie</Name>
+      <Name lang="nl">Microcefale corticale malformaties - kleine gestalte door RTTN-deficiëntie</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -231394,7 +230487,7 @@
     <Disorder id="22920">
       <OrphaCode>404443</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=404443</ExpertLink>
-      <Name lang="nl">Grote gestalte - intellectuele beperking - faciale dysmorfie-syndroom</Name>
+      <Name lang="nl">Syndroom van Tatton-Brown-Rahman</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -236859,7 +235952,7 @@
     <Disorder id="22744">
       <OrphaCode>398987</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=398987</ExpertLink>
-      <Name lang="nl">Maligne teratoom van het ovarium</Name>
+      <Name lang="nl">Maligne teratoom van ovarium</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -241909,7 +241002,7 @@
     <Disorder id="23427">
       <OrphaCode>442835</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=442835</ExpertLink>
-      <Name lang="nl">Onbepaalde epileptische encefalopathie met vroege aanvang</Name>
+      <Name lang="nl">Aspecifieke epileptische encefalopathie met vroege aanvang</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -255432,7 +254525,7 @@
     <Disorder id="8743">
       <OrphaCode>230</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=230</ExpertLink>
-      <Name lang="nl">Dopamine bèta-hydroxylasedeficiëntie</Name>
+      <Name lang="nl">Deficiëntie van dopamine-bèta-hydroxylase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -258956,7 +258049,7 @@
     <Disorder id="26573">
       <OrphaCode>508512</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=508512</ExpertLink>
-      <Name lang="nl">Congenitale multipele café-au-lait vlekken - verhoogde uitwisseling van zusterchromatiden-syndroom</Name>
+      <Name lang="nl">Intra-uteriene groeirestrictie - congenitale multipele café-au-lait vlekken - verhoogde uitwisseling van zusterchromatiden-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -259299,7 +258392,7 @@
     <Disorder id="26390">
       <OrphaCode>505652</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=505652</ExpertLink>
-      <Name lang="nl">CDKL5-gerelateerde epileptische encefalopathie</Name>
+      <Name lang="nl">CDKL5-deficiëntiestoornis</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -261749,7 +260842,7 @@
     <Disorder id="25998">
       <OrphaCode>500144</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=500144</ExpertLink>
-      <Name lang="nl">Progressieve encefalopathie - gehoorverlies - hypoplasie van de pons - hersenatrofie-syndroom met vroege aanvang</Name>
+      <Name lang="nl">Progressieve encefalopathie - gehoorverlies - hypoplasie van pons - hersenatrofie-syndroom met vroege aanvang</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -267914,9 +267007,9 @@
       <DisorderGroup id="36540">
         <Name lang="nl">Groep van aandoeningen</Name>
       </DisorderGroup>
-      <PrevalenceList count="11">
+      <PrevalenceList count="8">
         <Prevalence id="5195">
-          <Source>20566927[PMID]</Source>
+          <Source>PMID: 20566927</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -267926,12 +267019,12 @@
           <PrevalenceClass id="23739">
             <Name lang="nl">1-9 / 1 000 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.7</ValMoy>
+          <ValMoy>0.572</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="5196">
@@ -267949,12 +267042,12 @@
           <PrevalenceGeographic id="23795">
             <Name lang="nl">Europa</Name>
           </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="5197">
-          <Source>23809583[PMID]</Source>
+          <Source>PMID: 23809583</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -267972,46 +267065,8 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="5198">
-          <Source>1419751[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.3</ValMoy>
-          <PrevalenceGeographic id="24586">
-            <Name lang="nl">Ireland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="5199">
-          <Source>ISBN:801812658[OTHER]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.93</ValMoy>
-          <PrevalenceGeographic id="25006">
-            <Name lang="nl">Norway</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="5200">
-          <Source>6203284[PMID]</Source>
+        <Prevalence id="5204">
+          <Source>20566927[PMID]</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -268021,35 +267076,16 @@
           <PrevalenceClass id="23739">
             <Name lang="nl">1-9 / 1 000 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.88</ValMoy>
-          <PrevalenceGeographic id="24362">
-            <Name lang="nl">Finland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="5201">
-          <Source>2359725[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>1.9</ValMoy>
-          <PrevalenceGeographic id="24236">
-            <Name lang="nl">Croatia</Name>
+          <ValMoy>0.39</ValMoy>
+          <PrevalenceGeographic id="23949">
+            <Name lang="nl">Australia</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="5202">
-          <Source>2601109[PMID]</Source>
+        <Prevalence id="5206">
+          <Source>PMID: 27463098</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -268059,16 +267095,16 @@
           <PrevalenceClass id="23739">
             <Name lang="nl">1-9 / 1 000 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.35</ValMoy>
-          <PrevalenceGeographic id="24621">
-            <Name lang="nl">Japan</Name>
+          <ValMoy>0.14</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="5203">
-          <Source>20566927[PMID]</Source>
+        <Prevalence id="16421">
+          <Source>PMID: 25201089</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -268078,16 +267114,16 @@
           <PrevalenceClass id="23739">
             <Name lang="nl">1-9 / 1 000 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.1</ValMoy>
-          <PrevalenceGeographic id="24957">
-            <Name lang="nl">New Zealand</Name>
+          <ValMoy>0.28</ValMoy>
+          <PrevalenceGeographic id="25118">
+            <Name lang="nl">Romania</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="5204">
-          <Source>20566927[PMID]</Source>
+        <Prevalence id="16422">
+          <Source>PMID: 33095945</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -268097,28 +267133,28 @@
           <PrevalenceClass id="23739">
             <Name lang="nl">1-9 / 1 000 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.39</ValMoy>
-          <PrevalenceGeographic id="23949">
-            <Name lang="nl">Australia</Name>
+          <ValMoy>0.83</ValMoy>
+          <PrevalenceGeographic id="24936">
+            <Name lang="nl">Netherlands</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="5206">
-          <Source>PMID: 27463098</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
+        <Prevalence id="16423">
+          <Source>PMID: 33095945</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
           </PrevalenceType>
           <PrevalenceQualification id="23711">
             <Name lang="nl">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.14</ValMoy>
-          <PrevalenceGeographic id="25482">
-            <Name lang="nl">United States</Name>
+          <ValMoy>1.41</ValMoy>
+          <PrevalenceGeographic id="24936">
+            <Name lang="nl">Netherlands</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
@@ -269088,8 +268124,8 @@
       <OrphaCode>485350</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=485350</ExpertLink>
       <Name lang="nl">CLCN4-gerelateerde X-gebonden intellectuele achterstand-syndroom</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
@@ -273800,11 +272836,11 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="6059">
-          <Source>European Medicines Agency 2013[INST]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
+      <PrevalenceList count="3">
+        <Prevalence id="16440">
+          <Source>PMID: 28356407</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
           </PrevalenceType>
           <PrevalenceQualification id="23711">
             <Name lang="nl">Value and class</Name>
@@ -273812,7 +272848,7 @@
           <PrevalenceClass id="23746">
             <Name lang="nl">1-9 / 100 000</Name>
           </PrevalenceClass>
-          <ValMoy>3.0</ValMoy>
+          <ValMoy>4.2</ValMoy>
           <PrevalenceGeographic id="23795">
             <Name lang="nl">Europa</Name>
           </PrevalenceGeographic>
@@ -273820,18 +272856,18 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="6060">
-          <Source>21793646[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
+        <Prevalence id="16441">
+          <Source>PMID: 28356407</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
           </PrevalenceType>
           <PrevalenceQualification id="23711">
             <Name lang="nl">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
           </PrevalenceClass>
-          <ValMoy>55.0</ValMoy>
+          <ValMoy>5.1</ValMoy>
           <PrevalenceGeographic id="25482">
             <Name lang="nl">United States</Name>
           </PrevalenceGeographic>
@@ -273839,6 +272875,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="16442">
+          <Source>PMID: 28356407</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.9</ValMoy>
+          <PrevalenceGeographic id="24621">
+            <Name lang="nl">Japan</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="10963">
@@ -278282,11 +277337,11 @@
       <OrphaCode>64744</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=64744</ExpertLink>
       <Name lang="nl">IgG4-gerelateerde aandoening van schildklier</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="5895">
@@ -285494,7 +284549,7 @@
     <Disorder id="11108">
       <OrphaCode>77296</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=77296</ExpertLink>
-      <Name lang="nl">Morgagni-Stewart-Morelsyndroom</Name>
+      <Name lang="nl">Syndroom van Morgagni-Stewart-Morel</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -285900,11 +284955,11 @@
       <OrphaCode>79078</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79078</ExpertLink>
       <Name lang="nl">IgG4-gerelateerde dacryoadenitis en sialoadenitis</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="6230">
@@ -293513,28 +292568,9 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="5479">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
+      <PrevalenceList count="1">
         <Prevalence id="15427">
-          <Source>30376835[PMID]</Source>
+          <Source>PMID: 30376835</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -295765,8 +294801,8 @@
       <OrphaCode>537072</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=537072</ExpertLink>
       <Name lang="nl">PLG-gerelateerd erfelijk angio-oedeem met normale C1Inh</Name>
-      <DisorderType id="21443">
-        <Name lang="nl">Etiologisch subtype</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
       <DisorderGroup id="36554">
         <Name lang="nl">Subtype van aandoening</Name>
@@ -296246,55 +295282,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="27912">
-      <OrphaCode>537891</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=537891</ExpertLink>
-      <Name lang="nl">ANGPT1-gerelateerd erfelijk angio-oedeem met normale C1Inh</Name>
-      <DisorderType id="21443">
-        <Name lang="nl">Etiologisch subtype</Name>
-      </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="nl">Subtype van aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="14688">
-          <Source>28601681[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="14689">
-          <Source>ORPHANET_28601681[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>4.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="27913">
       <OrphaCode>538096</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=538096</ExpertLink>
@@ -297625,47 +296612,9 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="4">
-        <Prevalence id="5789">
-          <Source>15978100[PMID]_15127914[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.3</ValMoy>
-          <PrevalenceGeographic id="25482">
-            <Name lang="nl">United States</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="5790">
-          <Source>European Medicines Agency 2009[INST]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>25.5</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10877">
-          <Source>15127914[PMID]</Source>
+      <PrevalenceList count="1">
+        <Prevalence id="16433">
+          <Source>PMID: 18637802, 23729372, 31730475,</Source>
           <PrevalenceType id="23676">
             <Name lang="nl">Jaarlijkse incidentie</Name>
           </PrevalenceType>
@@ -297675,28 +296624,9 @@
           <PrevalenceClass id="23739">
             <Name lang="nl">1-9 / 1 000 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.12</ValMoy>
-          <PrevalenceGeographic id="25475">
-            <Name lang="nl">United Kingdom</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10878">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
+          <ValMoy>0.35</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
@@ -298242,11 +297172,11 @@
       <OrphaCode>49041</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=49041</ExpertLink>
       <Name lang="nl">IgG4-gerelateerde retroperitoneale fibrose</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="3">
         <Prevalence id="5688">
@@ -299212,7 +298142,7 @@
     <Disorder id="10670">
       <OrphaCode>51083</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=51083</ExpertLink>
-      <Name lang="nl">Familiaal korte QT-syndroom</Name>
+      <Name lang="nl">Familiaal kort-QT-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -299955,7 +298885,7 @@
     <Disorder id="28036">
       <OrphaCode>542301</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=542301</ExpertLink>
-      <Name lang="nl">Ernstige gecombineerde immuundeficiëntie door CARMIL2-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiëntie door CARMIL2-deficiëntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -300430,7 +299360,7 @@
     <Disorder id="28055">
       <OrphaCode>542643</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=542643</ExpertLink>
-      <Name lang="nl">Livedoïd vasculopathie</Name>
+      <Name lang="nl">Livedoïde vasculopathie</Name>
       <DisorderType id="21422">
         <Name lang="nl">Klinisch syndroom</Name>
       </DisorderType>
@@ -309112,7 +308042,7 @@
     <Disorder id="27494">
       <OrphaCode>528105</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=528105</ExpertLink>
-      <Name lang="nl">Hypohidrose - storing van de elektrolytenbalans - disfunctie van traanklieren - ichthyosis- xerostomie-syndroom</Name>
+      <Name lang="nl">Hypohidrose - verstoorde elektrolytenbalans - disfunctie van traanklieren - ichthyosis- xerostomie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -310505,7 +309435,7 @@
     <Disorder id="12260">
       <OrphaCode>93323</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93323</ExpertLink>
-      <Name lang="nl">Fibulaire hemimelie</Name>
+      <Name lang="nl">Hemimelie van fibula</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -318249,7 +317179,7 @@
     <Disorder id="11268">
       <OrphaCode>79242</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79242</ExpertLink>
-      <Name lang="nl">Holocarboxylase-synthetasedeficiëntie</Name>
+      <Name lang="nl">Deficiëntie van holocarboxylase-synthetase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -332173,7 +331103,7 @@
     <Disorder id="12888">
       <OrphaCode>97297</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=97297</ExpertLink>
-      <Name lang="nl">Bohring-Opitzsyndroom</Name>
+      <Name lang="nl">Syndroom van Bohring-Opitz</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -334732,7 +333662,7 @@
     <Disorder id="12593">
       <OrphaCode>95434</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=95434</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve cerebellaire ataxie - saccadische intrusie-syndroom</Name>
+      <Name lang="nl">Autosomaal recessieve cerebellaire ataxie - bewegingsstoornis-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -336671,26 +335601,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="7360">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>3.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
+      <PrevalenceList count="1">
         <Prevalence id="7361">
           <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
@@ -336706,8 +335617,8 @@
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
       </PrevalenceList>
@@ -340242,55 +339153,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="14086">
-      <OrphaCode>99069</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99069</ExpertLink>
-      <Name lang="nl">Univentriculair hart met enkelvoudige atrioventriculaire klep</Name>
-      <DisorderType id="21450">
-        <Name lang="nl">Klinisch subtype</Name>
-      </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="nl">Subtype van aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="7776">
-          <Source>15531940[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>2.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="7777">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="14080">
       <OrphaCode>99063</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99063</ExpertLink>
@@ -341094,11 +339956,11 @@
       <OrphaCode>99748</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99748</ExpertLink>
       <Name lang="nl">Pontiac-koorts</Name>
-      <DisorderType id="21450">
-        <Name lang="nl">Klinisch subtype</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
       </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="nl">Subtype van aandoening</Name>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="7799">
@@ -352811,6 +351673,19 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="28931">
+      <OrphaCode>580933</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=580933</ExpertLink>
+      <Name lang="nl">Letale ontwikkelingsdefecten van hersenen en hart</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="0">
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="13772">
       <OrphaCode>98755</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98755</ExpertLink>
@@ -358554,8 +357429,8 @@
       <OrphaCode>100054</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100054</ExpertLink>
       <Name lang="nl">F12-gerelateerd erfelijk angio-oedeem met normale C1Inh</Name>
-      <DisorderType id="21443">
-        <Name lang="nl">Etiologisch subtype</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
       <DisorderGroup id="36554">
         <Name lang="nl">Subtype van aandoening</Name>
@@ -359691,11 +358566,11 @@
       <OrphaCode>99989</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99989</ExpertLink>
       <Name lang="nl">Intermediair DEND-syndroom</Name>
-      <DisorderType id="21450">
-        <Name lang="nl">Klinisch subtype</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
       </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="nl">Subtype van aandoening</Name>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="10785">
@@ -359723,11 +358598,11 @@
       <OrphaCode>99981</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99981</ExpertLink>
       <Name lang="nl">Apneu door prematuriteit</Name>
-      <DisorderType id="21450">
-        <Name lang="nl">Klinisch subtype</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
       </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="nl">Subtype van aandoening</Name>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="7907">
@@ -362664,7 +361539,7 @@
     <Disorder id="14458">
       <OrphaCode>99885</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99885</ExpertLink>
-      <Name lang="nl">Permanente neonatale diabetes mellitus</Name>
+      <Name lang="nl">Geïsoleerde permanente neonatale diabetes mellitus</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
